FY2011 · ended Oct 31, 2011 · Revenue $0 · Filed Feb 13, 2014
3DX Industries, Inc. (DDDX) files with the SEC under industry code 2750, Commercial Printing.
Revenue
$0
Net income (TTM)
$24.93M
+270.6% vs year-ago TTM
Operating cash flow (TTM)
$-299,119
-25.3% vs year-ago TTM
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
37.46M
+18.6% vs prior year
Net cash
$-497,926
FY 2014
Operating margin
—
Company profile
- Industry
- Commercial Printing (SIC 2750)
- Listed as
- DDDX (OTC)
- Fiscal year ends
- October 31
- Incorporated in
- NV
- Headquarters
- Ferndale, WA
- SEC filer status
- Smaller reporting company
- SEC CIK
- 1453122
- Former names
- Amarok Resources, Inc. (until Dec 31, 2013); Ukragro Corp (until Mar 17, 2010)
Other Commercial Printing companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2014 Oct 31, 2014 |
FY 2013 Oct 31, 2013 |
FY 2012 Oct 31, 2012 |
FY 2011 Oct 31, 2011 |
|---|---|---|---|---|
| Revenue | — | — | — | $0 |
| Operating income | $6.1M | $436,272 | $1.2M | — |
| Net income | $11.0M | $446,548 | -$454,807 | -$2.0M |
| Operating cash flow | -$288,246 | -$95,164 | -$214,083 | -$1.7M |
| Total assets | $1.2M | $694,234 | $712,280 | $985,960 |
| Total liabilities | $2.3M | $465,421 | — | $55,021 |
| Stockholders' equity | -$1.1M | $228,813 | $527,284 | $930,939 |
| Cash and investments | $2,074 | $2,460 | $18,824 | $267,995 |
| Total debt | $500,000 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change, Restatement
|
Jan 22, 2018 | Mar 29, 2017 |
| 10-K | Annual report | Jan 17, 2018 | Oct 31, 2016 |
| 10-Q | Quarterly report | Jan 17, 2018 | Jan 31, 2017 |
| 10-Q | Quarterly report | Jan 17, 2018 | Jul 31, 2016 |
| 10-K | Annual report | Jan 17, 2018 | Oct 31, 2015 |
| 10-Q | Quarterly report | Jan 17, 2018 | Jan 31, 2016 |
All 83 3DX Industries, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.